# BrightSpring Health (BTSG) — Earnings

BTSG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/btsg/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.45 |
| EPS estimate | $0.40 |
| EPS surprise | +13.55% |
| Revenue surprise | +5.80% |
| Revenue | $3.9B |
| Revenue estimate | $3.7B |
| Reported | Jul 31, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1865782/000119312526326654/btsg-20260731.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/4ab3ec8e-2ed8-b59e-72ee-d87dc2bbf9f2.html) |

BrightSpring Health reported Q2 2026 results on July 31, 2026. Earnings per share were $0.45, ahead of the $0.40 estimate by 13.55%. Revenue was $3.9 billion against a $3.7 billion consensus, a beat of 5.80%. Compared with Q2 2025, EPS rose about 105% from $0.22 and revenue rose about 26% from $3.1 billion. Both were the highest in the table.

The record is fairly short, with 11 quarters starting from Q4 2023. That first quarter was a loss of $0.06 per share. Every quarter since has been profitable. Annual EPS was $0.55 in 2024 and $1.04 in 2025, up about 89%. The first half of 2026 adds up to $0.84, about double the $0.41 of the first half of 2025. Revenue rose from $2.4 billion in Q4 2023 to $3.9 billion. BrightSpring beat the EPS estimate in seven of the 11 quarters. The most recent miss was Q4 2025, at 3.85% below.

Q3 results came on November 1, 2024 and October 20, 2025, the only two third-quarter reports in the table. That points to late October or early November 2026 for the next report. It will show whether the year-over-year growth of the first half carries into the third quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 31, 2026 | $0.40 | $0.45 | 13.55% | $3.7B | $3.9B |
| Q1 2026 | May 1, 2026 | $0.31 | $0.39 | 26.25% | $3.4B | $3.6B |
| Q4 2025 | Feb 27, 2026 | $0.34 | $0.33 | -3.85% | $3.4B | $3.6B |
| Q3 2025 | Oct 20, 2025 | $0.25 | $0.30 | 21.07% | $3.2B | $3.3B |
| Q2 2025 | Aug 1, 2025 | $0.19 | $0.22 | 17.58% | $3.0B | $3.1B |
| Q1 2025 | May 2, 2025 | $0.09 | $0.19 | 108.79% | $2.7B | $2.9B |
| Q4 2024 | Mar 6, 2025 | $0.21 | $0.22 | 3.82% | $3.0B | $3.1B |
| Q3 2024 | Nov 1, 2024 | $0.15 | $0.11 | -28.53% | $2.7B | $2.9B |
| Q2 2024 | Aug 2, 2024 | $0.13 | $0.10 | -25.87% | $2.6B | $2.7B |
| Q1 2024 | May 2, 2024 | $0.04 | $0.12 | 220.00% | $2.3B | $2.6B |
| Q4 2023 | Feb 29, 2024 | $0.10 | −$0.06 | -157.42% | $2.4B | $2.4B |

## Frequently Asked Questions

### When did BrightSpring Health (BTSG) last report earnings?

BrightSpring Health last reported on Jul 31, 2026, covering fiscal Q2 2026.

### Did BTSG beat earnings estimates?

Yes. BrightSpring Health reported EPS of $0.45 for Q2 2026 against a $0.40 estimate — a 13.55% beat.

### How much revenue did BTSG report last quarter?

BrightSpring Health reported $3.9B in revenue for Q2 2026, against a consensus estimate of $3.7B.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).